<?xml version="1.0" ?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="section">
    <meta>
      <identification source="#publicresource">
        <FRBRWork>
          <FRBRthis value="/us-ky/act/krs/439.655"/>
          <FRBRuri value="/us-ky/act/krs/439.655"/>
          <FRBRdate date="2025-12-31" name="enacted"/>
          <FRBRauthor href="#ky-legislature"/>
          <FRBRcountry value="us-ky"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/us-ky/act/krs/439.655/eng"/>
          <FRBRuri value="/us-ky/act/krs/439.655/eng"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#publicresource"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/us-ky/act/krs/439.655/eng/akn"/>
          <FRBRuri value="/us-ky/act/krs/439.655/eng/akn"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#cosilico"/>
        </FRBRManifestation>
      </identification>
      <references source="#cosilico">
        <TLCOrganization eId="ky-legislature" href="/ontology/organization/us-ky/legislature" showAs="Kentucky General Assembly"/>
        <TLCOrganization eId="publicresource" href="https://public.resource.org" showAs="Public.Resource.Org"/>
        <TLCOrganization eId="cosilico" href="https://cosilico.ai" showAs="Cosilico"/>
      </references>
    </meta>
    <body>
      <section eId="sec_439_655">
        <num>439.655</num>
        <content>
          <p>If reentry drug supervision pilot program participation as outlined in  is impracticable due to inpatient treatment or similar circumstances in which the participant is being monitored by an authorized third party, the participant shall be placed in suspended status. Upon release from the authorized third party, the participant shall resume participation in the reentry drug supervision pilot program. During the time in which the participant is suspended, no credit shall be earned toward the completion of the two (2) pilot program phases.</p>
        </content>
      </section>
    </body>
  </act>
</akomaNtoso>
